Anthem Biosciences Limited Share Price

Equities

Market Closed - NSE India S.E. Other stock markets 04:35:01 09/03/2026 pm IST			5-day change	1st Jan Change
660.15 ^INR	-0.46%		-3.96%	+1.33%

09/03	Viridity Tone LLP sold 20.3 mln shares in Anthem Biosciences via bulk deal on BSE	RE
09/02	JM Financial Upgrades Anthem BioSciences to Buy from Add; Price Target is INR798	MT

Capitalization	37TCr 402.43Cr 347.14Cr 313.47Cr 300.42Cr 546.01Cr 570.89Cr 3.7TCr 1.48TCr 18TCr 1.51TCr 1.48TCr 64TCr	P/E ratio 2026 *	63.4x	P/E ratio 2027 *	52.4x
Enterprise value	36TCr 394.16Cr 340Cr 307.03Cr 294.25Cr 534.79Cr 559.16Cr 3.62TCr 1.45TCr 17TCr 1.48TCr 1.45TCr 62TCr	EV / Sales 2026 *	17.3x	EV / Sales 2027 *	14.1x
Free-Float	-	Yield 2026 *	1.59%	Yield 2027 *	1.86%

Timeframe

Style

09/03	Viridity Tone LLP sold 20.3 mln shares in Anthem Biosciences via bulk deal on BSE	RE
09/02	JM Financial Upgrades Anthem BioSciences to Buy from Add; Price Target is INR798	MT
05/02	Anthem Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
05/02	Anthem Biosciences posts Dec-quarter consol profit of 928.2 million rupees	RE
21/01	387,171,781 Equity Shares of Anthem Biosciences Limited are subject to a Lock-Up Agreement Ending on 21-JAN-2026.	CI
22/12	Anthem Biosciences Limited(BSE:544449) added to S&P Global BMI Index	CI
28/11	Nomura Starts Anthem Biosciences at Buy With INR740 Price Target	MT
08/11	Anthem Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
15/25/15	8,912,499 Equity Shares of Anthem Biosciences Limited are subject to a Lock-Up Agreement Ending on 15-OCT-2025.	CI
17/25/17	India's Urban Company soars 74% in trading debut, hits about $3 billion valuation	RE
14/25/14	8,912,500 Equity Shares of Anthem Biosciences Limited are subject to a Lock-Up Agreement Ending on 14-AUG-2025.	CI
14/25/14	Anthem Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
13/25/13	Anthem Announces Re-Designation of Mr. Ravi Kalla as Chief Information Officer	CI

09/02	JM Financial Upgrades Anthem BioSciences to Buy from Add; Price Target is INR798	MT
28/11	Nomura Starts Anthem Biosciences at Buy With INR740 Price Target	MT

Manager	Title	Age	Since
Ganesh Sambasivam CTO	Chief Tech/Sci/R&D Officer	60	04/08/2006
Chandrappa Ravindra COO	Chief Operating Officer	59	27/09/2006
Ajay Bharadwaj CEO	Chief Executive Officer	65	13/06/2006

Director	Title	Age	Since
Ajay Bharadwaj CHM	Chairman	65	01/01/2021
Ganesh Sambasivam BRD	Director/Board Member	60	04/08/2006
Chandrappa Ravindra BRD	Director/Board Member	59	27/09/2006

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ANTHEM BIOSCIENCES LIMITED	-0.46%	-3.96%	-	-	405.29Cr
ELI LILLY AND COMPANY	+1.82%	-0.94%	+15.96%	+218.25%	88TCr
JOHNSON & JOHNSON	+0.91%	-2.40%	+45.53%	+60.40%	58TCr
ABBVIE INC.	-1.16%	-2.91%	+6.14%	+54.36%	41TCr
ROCHE HOLDING AG	-2.58%	-8.40%	+8.27%	+25.86%	35TCr
NOVARTIS AG	+1.66%	-3.59%	+24.16%	+65.94%	30TCr
ASTRAZENECA PLC	-0.40%	-5.31%	+19.63%	+32.91%	30TCr
MERCK & CO., INC.	+1.14%	-3.54%	+23.73%	+8.84%	29TCr
AMGEN INC.	+2.01%	-2.26%	+16.04%	+66.96%	20TCr
GILEAD SCIENCES, INC.	+1.88%	-2.27%	+24.89%	+85.73%	18TCr
Average	+0.05%	-3.76%	+20.48%	+68.80%	34.93TCr
Weighted average by Cap.	-0.46%	-3.16%	+21.08%	+91.81%

	2026 *	2027 *
Net sales	2.1TCr 23Cr 20Cr 18Cr 17Cr 31Cr 32Cr 210.05Cr 84Cr 1.01TCr 86Cr 84Cr 3.61TCr	2.55TCr 28Cr 24Cr 22Cr 21Cr 37Cr 39Cr 254.06Cr 101.88Cr 1.22TCr 103.71Cr 101.48Cr 4.37TCr
Net income	591.19Cr 6.42Cr 5.54Cr 5Cr 4.79Cr 8.71Cr 9.1Cr 59Cr 24Cr 282.8Cr 24Cr 24Cr 1.01TCr	708.91Cr 7.7Cr 6.64Cr 5.99Cr 5.74Cr 10Cr 11Cr 71Cr 28Cr 339.11Cr 29Cr 28Cr 1.22TCr
Net Debt	-762Cr -8.27Cr -7.13Cr -6.44Cr -6.17Cr -11Cr -12Cr -76Cr -31Cr -364.51Cr -31Cr -30Cr -1.31TCr	-1.1TCr -12Cr -10Cr -9.33Cr -8.94Cr -16Cr -17Cr -110.1Cr -44Cr -527.59Cr -45Cr -44Cr -1.89TCr